HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Left ventricular mass regression with amlodipine in elderly hypertensives.

Abstract
We evaluated effect of amlodipine therapy on left ventricular (LV) mass and function indices in 34 elderly hypertensives having echocardiographic evidence of left ventricular hypertrophy (LVH). LV mass and LV function indices were evaluated before and after 4 months of effective amlodipine therapy. Fourteen patients completed the study. Blood pressure was effectively controlled in all the patients; dose requirement of amlodipine being 5 mg/day in 8 and 10 mg/day in 6 patients. We found significant regression of LV mass indices such as thickness of interventricular septum (IVS) and left ventricular posterior wall (LVPW), and LV mass index after 4 months of amlodipine therapy. However, LV function indices did not alter following treatment. In conclusion, amlodipine therapy besides effectively controlling BP in elderly hypertensives, produced significant regression of LV mass indices without affecting the LV function.
AuthorsN K Singh, S K Gupta, B V Agrawal
JournalClinical and experimental hypertension (New York, N.Y. : 1993) (Clin Exp Hypertens) 1999 Jan-Feb Vol. 21 Issue 1-2 Pg. 113-9 ISSN: 1064-1963 [Print] England
PMID10052647 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Calcium Channel Blockers
  • Amlodipine
Topics
  • Aged
  • Aged, 80 and over
  • Amlodipine (therapeutic use)
  • Blood Pressure (drug effects)
  • Calcium Channel Blockers (therapeutic use)
  • Echocardiography
  • Female
  • Follow-Up Studies
  • Heart Rate (drug effects)
  • Heart Ventricles (diagnostic imaging)
  • Humans
  • Hypertension (complications, drug therapy, physiopathology)
  • Hypertrophy, Left Ventricular (drug therapy, etiology, physiopathology)
  • Male
  • Middle Aged
  • Stroke Volume (drug effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: